Pharmacology

Triple Therapy for Chronic Hepatitis C; The Arguments Against Sodium Polystyrene Sulfonate; Low-Dose Vaporized Marijuana Relieves Neuropathic Pain

Genotype 1 is the most difficult of the 6 hepatitis C genotypes to treat. Currently, the preferred approach is combination treatment with pegylated interferon (PEG-IFN) plus ribavirin (RBV) in patients with an uncomplicated infection, but only half of patients reach sustained viral response (SVR) at 24 weeks; the rates are even lower in black patients: as low as 19%.


 

Recommended Reading

Veterans May Have Been Exposed to HIV While Receiving VA Care
Federal Practitioner
Endoscopic Equipment Errors Leave Veterans at Risk
Federal Practitioner
Living with Liver Cancer
Federal Practitioner
VA Reports More Infections With Possible Links to Endoscopic Errors
Federal Practitioner
VA Report Says Endoscope Problems Continue
Federal Practitioner
VHA Facilities Improve Colonoscope Reprocessing Compliance
Federal Practitioner
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Federal Practitioner
Hepatocellular Carcinoma: To Biopsy or Not?
Federal Practitioner
Safe Use of Buprenorphine/Naloxone in a Veteran With Acute Hepatitis C Virus Infection
Federal Practitioner
"Individualizing" Glucose Monitors Can Help Reduce Infection
Federal Practitioner